Einfluss des Body Mass Index (BMI) auf die Suppression der Östradiol-Spiegel mittels Aromatase-Inhibitoren (AI's) bei postmenopausalen Brustkrebspatientinnen: eine prospektive „Proof of Principle“ Studie
Georg Pfeiler(Medical University of Vienna), P Dubsky, Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), M. Seifert, Robert Königsberg(Kaiser-Franz-Josef-Spital), Ruth Exner(Comprehensive Cancer Center Vienna), J Zellinger(Comprehensive Cancer Center Vienna), M Maroske(Comprehensive Cancer Center Vienna), Peyman Hadji(Philipps University of Marburg), Ga‐Young Ban(Ajou University), CF Singer(Innsbruck Medical University), Florian Fitzal
Cited by 0
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830